{"database": "openregs", "table": "documents", "rows": [["FDA-2003-N-0196-0055", "FDA", "FDA-2003-N-0196", "Initial Determination and Feedback Letter from FDA/CDER to L'Oreal USA Products, Inc re Time and Extent Application (TEA) Drometrizole Trisiloxane for use in Over-the-Counter (OTC) Sunscreens", "Other", "Letter(s)", "2014-08-29T04:00:00Z", 2014, 8, "2014-08-29T04:00:00Z", null, "2014-08-29T21:20:12Z", null, 0, 0, "09000064818511a4"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-N-0196-0055"], "units": {}, "query_ms": 0.42438902892172337, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}